By Alan Cassels, Brownstone Institute
Vanity can make people do stupid things. Want to look better in a bathing suit? Great goal, now with a small potential wrinkle: the treatment your doctor prescribes might be so good you won’t see your fat anymore, because that treatment made you go blind.
This latest dispatch from the world of pharmaceutical safety comes from that drug class that is a gift that keeps on giving, the blockbuster weight-loss drugs known as GLP-1’s. Branded as Ozempic, Wegovy, or the pill version Rybelsus, these drugs continue to be hailed as modern miracles, loved by Oprah and other “influencers.”
They are the darlings of Tech billionaires whose love affair with “innovative” cosmetic pharmacology has created some of the most costly and otherworldly disfigurements on the planet.
You gotta be careful talking about these drugs because almost everyone you know, and their cousin, has been experimenting with them. Slagging OzempicZ these days has been likened to a modern form of fat-shaming which is a line even an unwoke person like myself would never cross.
Anyways, the drugs promise to shrink your waistline, rein in your appetite, and possibly extend your life. We hope. But now here’s a new twist in the plot. According to a recent study published in the British Journal of Ophthalmology, people taking Wegovy may face a five-fold greater risk of a condition charmingly known as NAION for non-arteritic anterior ischemic optic neuropathy. The European Medicines Agency released a warning last year about this risk, known in plainer English as an “eye stroke.”
Consider the optic nerve as the cable connecting your eyeball to the brain’s projection room. Now imagine that cable suddenly losing blood flow. The lights flicker. The film stops. Curtains down.
Vision gone.
This is the pharmaceutical version of “Oops, didn’t see that coming.”
As usual in the world of drug safety warnings, this blindness risk is described as rare, which I hope you will allow me the indulgence to translate. It means: “Don’t worry your pretty little head about going blind, just remember bathing suit season is coming.”
Apparently it affects about one in 10,000 users. While that might seem ‘small,’ it is a similar order of magnitude as the risk of a middle-aged healthy man like me, dying from Covid in 2020; a magnitude of risk so small yet so wildly exaggerated, that it caused massive paroxysms of regulatory safetyism which essentially shut down our societies.
Here no individual looking at these data will even blink an eye at a 1 in 10,000 risk of going blind but when you multiply that by the millions of people on the GLP-1 bandwagon, that’s thousands more blind people than before. The real risk could be higher, 10, possibly 100 times higher but we won’t really know until the experiment runs its course.
On this file regulators are quick to reassure us that the “benefit-risk profile remains favorable,” a cliché so bland it has pretty much lost its meaning among researchers like me who actually pay attention to these things. When the manufacturers face the bad news they turn up their noses like someone reacting to a fart in an elevator, and go back to emphasizing the positives: fewer heart attacks, better blood sugar control, great weight control. It’s all rainbows and roses. Nothing to smell here. Sure hope they’re right.
Still, there’s something darkly comic about the situation. Millions of people are sprinting toward these injections hoping to see a thinner version of themselves in the mirror…while a small but real number might end up not seeing much of anything at all.
This irony practically writes itself.
The study suggests the higher dose used in Wegovy, compared with Ozempic, might be the culprit. Faster weight loss, stronger effect, higher risk. In other words, when it comes to these drugs, sprinting faster towards a more ideal weight may literally blind you.
The lesson I’d leave to consumers after having spent 30 years sifting through the underwear drawer of drug safety: you never know what gems you’re gonna find in there. Sad, and weird, but true.
The arc of a drug’s life is more predictable: when a new drug first bursts onto the scene, it arrives wrapped in glossy headlines, celebrity testimonials, and enthusiastic doctors. The adverse effects, meanwhile, start small and build. They take time to be discovered and each new adverse event, each new patient hurt, each new pancreatitis or blindness case adds to the balance sheet. We learn a little bit more and every patient becomes another data point in a giant, global experiment.
Most people will be fine.
Some will lose weight. Temporarily.
And a tiny fraction may lose something else entirely. When you start a brand-new drug, you’re also opening a box of surprises. Go into it with your eyes wide open. At least on the blindness front, you can’t now say: I didn’t see that coming.

QTR’s Disclaimer: Please read my full legal disclaimer on my About page here. This post represents my opinions only. In addition, please understand I am an idiot and often get things wrong and lose money. I may own or transact in any names mentioned in this piece at any time without warning. Contributor posts and aggregated posts have been hand selected by me, have not been fact checked and are the opinions of their authors. They are either submitted to QTR by their author, reprinted under a Creative Commons license with my best effort to uphold what the license asks, or with the permission of the author.
This is not a recommendation to buy or sell any stocks or securities, just my opinions. I often lose money on positions I trade/invest in. I may add any name mentioned in this article and sell any name mentioned in this piece at any time, without further warning. None of this is a solicitation to buy or sell securities. I may or may not own names I write about and are watching. Sometimes I’m bullish without owning things, sometimes I’m bearish and do own things. Just assume my positions could be exactly the opposite of what you think they are just in case. If I’m long I could quickly be short and vice versa. I won’t update my positions. All positions can change immediately as soon as I publish this, with or without notice and at any point I can be long, short or neutral on any position. You are on your own. Do not make decisions based on my blog. I exist on the fringe. If you see numbers and calculations of any sort, assume they are wrong and double check them. I failed Algebra in 8th grade and topped off my high school math accolades by getting a D- in remedial Calculus my senior year, before becoming an English major in college so I could bullshit my way through things easier.
The publisher does not guarantee the accuracy or completeness of the information provided in this page. These are not the opinions of any of my employers, partners, or associates. I did my best to be honest about my disclosures but can’t guarantee I am right; I write these posts after a couple beers sometimes. I edit after my posts are published because I’m impatient and lazy, so if you see a typo, check back in a half hour. Also, I just straight up get shit wrong a lot. I mention it twice because it’s that important.



The idea of popping pills to 'cure' lifestyle problems is a modern curse.
Scary shit, maybe just get a couple more covid vaccines instead.